by Stacey Hawkins | Jan 22, 2019 | Immunotherapies
Further Down The Cancer Treatment Road With CARs Chimeric antigen receptor (CAR) T-cell therapies have captured the imagination of both scientists and the public. The ability to genetically alter a patient’s own cells to fight cancer has revolutionized the treatment... 
by Stacey Hawkins | May 19, 2016 | Uncategorized
BIOPHARMA’S DARLING Immunotherapy is the current biopharma darling, garnering massive investment and media attention. Ranging from monoclonal antibodies to engineered T-cells, companies are rapidly learning how to harness the power of the immune system to fight... 
by Stacey Hawkins | Sep 24, 2015 | Oncology
The Metabolics Of Cancer Tackling cancer requires a multi-pronged strategy. Currently, many of the cancer drugs on the market work by inhibiting the signaling pathways that activate cell division. These pathways are often the root cause of cancer—a mutated gene leads... 
by Stacey Hawkins | May 7, 2015 | Uncategorized
THE INNER WORKINGS OF YOUR IMMUNE SYSTEM What do monoclonal antibodies, CAR-T therapy, and 3D vaccines all have in common? They are immunotherapies, or therapies that activate a patient’s own immune system to fight or prevent a disease. While immune system activation... 
by Stacey Hawkins | Mar 19, 2015 | Uncategorized
HBO shines light on novel immunotherapies HBO’s Vice news program selected a few promising technologies from the immunotherapy pipeline to feature in its Killing Cancer episode. Vice’s heartrending human interest stories illustrated the potential of three...
